Comparison of one-year outcomes following coronary artery stenting in diabetic versus nondiabetic patients (from the Enhanced Suppression of the Platelet IIb/IIIa Receptor With Integrilin Therapy [ESPRIT] Trial)

For patients undergoing nonurgent coronary stent implantation, blockade of the glycoprotein IIb/IIIa receptor with eptifibatide reduces the incidence of ischemic complications. We evaluated the interaction of eptifibatide with diabetes in patients who underwent this procedure by analyzing the 1-year...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American journal of cardiology 2002-09, Vol.90 (6), p.585-590
Hauptverfasser:	Labinaz, Marino, Madan, Mina, O’Shea, J.Conor, Kilaru, Rakhi, Chin, Wai, Pieper, Karen, McGuire, Darren K, Saucedo, Jorge F, Talley, J.David, Lui, Henry, Kitt, Michael M, Califf, Robert M, Tcheng, James E
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Aged Biological and medical sciences Blood Vessel Prosthesis Implantation Blood vessels Clinical outcomes Coronary Artery Disease - complications Coronary Artery Disease - mortality Coronary Artery Disease - therapy Diabetes Diabetes Complications Diabetes Mellitus - mortality Diabetes Mellitus - therapy Diseases of the cardiovascular system Drug therapy Endpoint Determination Eptifibatide Female Follow-Up Studies Humans Hypoglycemic Agents - therapeutic use Incidence Insulin - therapeutic use Male Medical procedures Medical sciences Middle Aged Myocardial Infarction - etiology Myocardial Infarction - mortality Peptides - therapeutic use Platelet Aggregation Inhibitors - therapeutic use Platelet Glycoprotein GPIIb-IIIa Complex - therapeutic use Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) Stents Survival Analysis Time Factors Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!